Steven C. Jones's most recent trade in Neogenomics Inc. was a trade of 100,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 7, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Neogenomics Inc. | Steven C. Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2021 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Steven C. Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.15 per share. | 07 Jan 2021 | 100,000 | 1,100,000 (1%) | 0% | 7.2 | 715,000 | Common Stock |
| Neogenomics Inc. | Steven C. Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.27 per share. | 07 Jan 2021 | 10,000 | 82,932 (0%) | 0% | 7.3 | 72,700 | Common Stock |
| Neogenomics Inc. | Steven C. Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2021 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Steven C. Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2021 | 4,269 | 0 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Steven C. Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.52 per share. | 07 Jan 2021 | 4,269 | 90,218 (0%) | 0% | 22.5 | 96,138 | Common Stock |
| Neogenomics Inc. | Steven C. Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jan 2021 | 3,017 | 0 | - | - | Stock Option (Right to Buy) | |
| Neogenomics Inc. | Steven C. Jones | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.60 per share. | 07 Jan 2021 | 3,017 | 85,949 (0%) | 0% | 11.6 | 34,997 | Common Stock |
| Neogenomics Inc. | Steven C. Jones | Director | Sale of securities on an exchange or to another person at price $ 51.67 per share. | 10 Dec 2020 | 25,000 | 1,000,000 (0%) | 0% | 51.7 | 1,291,750 | Common Stock |
| Neogenomics Inc. | Steven C. Jones | Director | Sale of securities on an exchange or to another person at price $ 50.52 per share. | 10 Dec 2020 | 25,000 | 1,025,000 (0%) | 0% | 50.5 | 1,263,000 | Common Stock |
| Neogenomics Inc. | Steven C. Jones | Director | Sale of securities on an exchange or to another person at price $ 50.30 per share. | 10 Dec 2020 | 20,000 | 1,050,000 (1%) | 0% | 50.3 | 1,006,000 | Common Stock |
| Neogenomics Inc. | Steven C. Jones | Director | Sale of securities on an exchange or to another person at price $ 48.07 per share. | 03 Dec 2020 | 64,394 | 1,115,658 (1%) | 0% | 48.1 | 3,095,420 | Common Stock |
| Neogenomics Inc. | Steven C. Jones | Director | Sale of securities on an exchange or to another person at price $ 49.45 per share. | 03 Dec 2020 | 45,658 | 1,070,000 (1%) | 0% | 49.4 | 2,257,788 | Common Stock |
| Neogenomics Inc. | Steven C. Jones | Director | Sale of securities on an exchange or to another person at price $ 48.03 per share. | 03 Dec 2020 | 19,948 | 1,180,052 (1%) | 0% | 48.0 | 958,102 | Common Stock |
| Neogenomics Inc. | Steven C. Jones | Director | Sale of securities on an exchange or to another person at price $ 36.95 per share. | 28 Sep 2020 | 141,049 | 1,200,000 (1%) | 0% | 37.0 | 5,211,761 | Common Stock |
| Neogenomics Inc. | Steven C. Jones | Director | Sale of securities on an exchange or to another person at price $ 36.55 per share. | 28 Sep 2020 | 81,000 | 97,932 (0%) | 0% | 36.6 | 2,960,550 | Common Stock |
| Neogenomics Inc. | Steven C. Jones | Director | Sale of securities on an exchange or to another person at price $ 36.34 per share. | 28 Sep 2020 | 38,951 | 1,341,049 (1%) | 0% | 36.3 | 1,415,479 | Common Stock |
| Neogenomics Inc. | Steven C. Jones | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Sep 2020 | 25,000 | 72,932 (0%) | 0% | 0 | Common Stock | |
| Neogenomics Inc. | Steven C. Jones | Director | Sale of securities on an exchange or to another person at price $ 36.56 per share. | 28 Sep 2020 | 19,000 | 178,932 (0%) | 0% | 36.6 | 694,640 | Common Stock |
| Neogenomics Inc. | Steven C. Jones | Director | Sale of securities on an exchange or to another person at price $ 36.98 per share. | 08 Sep 2020 | 71,583 | 1,417,991 (1%) | 0% | 37.0 | 2,647,139 | Common Stock |
| Neogenomics Inc. | Steven C. Jones | Director | Sale of securities on an exchange or to another person at price $ 37.13 per share. | 08 Sep 2020 | 37,991 | 1,380,000 (1%) | 0% | 37.1 | 1,410,606 | Common Stock |
| Neogenomics Inc. | Steven C. Jones | Director | Sale of securities on an exchange or to another person at price $ 36.13 per share. | 08 Sep 2020 | 10,426 | 1,489,574 (1%) | 0% | 36.1 | 376,691 | Common Stock |